Publications Repository - Helmholtz-Zentrum Dresden-Rossendorf

1 Publication

Novel High Affinity Histone Deacetylase Inhibitors as Potential Radiotracers for PET

Clauß, O.; Schäker-Hübner, L.; Scheunemann, M.; Hansen, F. K.; Brust, P.

Epigenetics investigates heritable phenotype changes that do not involve alterations in the DNA sequence. The related phenomena play a key role in gene expression by enzyme-mediated post-translational modifications (PTMs) of proteins. One of the most relevant modifications is the process of deacetylation of the lysine side chains on histones, which are regulated by histone deacetylases (HDACs). The catalyzed deacetylation of lysine residues on histones modulates the chromatin and thus influences the gene expression and transcription. The class I histone deacetylases 1, 2 and 3 are overexpressed in several types of cancer, neurodegenerative diseases and inflammation. Inhibition of those zinc-dependent HDACs relaxes the chromatin structure and can result in transcriptional activation and anticancer effects, e.g. cell cycle arrest and induced differentiation. Consequently, radiolabeled HDAC inhibitors have emerged as a potential tool for the diagnostic imaging of tumors by positron emission tomography (PET). [1]
The aim of this work is the development of novel highly affine and selective fluorine-containing derivatives of a class I selective HDAC inhibitor to obtain the corresponding 18F-labeled PET radiotracers with an ortho-aminoanilide as zinc-binding motif for targeting class I HDACs in tumors. Recently, we discovered a new highly affine HDAC 1 ligand LSH-A30 with an IC50 for HDAC 1 inhibition of 4.4 ± 0.1 nM. In this connection, the structure of LSH-A30 serves as lead for the development of a series of fluorinated reference compounds, which are currently synthesized. The binding affinities and selectivities towards the class I HDAC isoforms will be determined. Our strategy is mainly focused on the medicinal chemistry of fluorine-containing derivatives, which are suitable for direct and indirect nucleophilic radiofluorination. For the most promising compounds, precursors for radiolabeling will be synthesized, the evaluation of physicochemical properties, e.g. stability and lipophilicity of the radiolabeled compounds will be assessed and further in vitro and in vivo investigations will be performed.

Keywords: HDAC inhibitors; PET tracer development; ortho-aminoanilides

  • Open Access Logo Poster
    GDCh Wissenschaftsforum Chemie 2019, 15.-18.09.2019, Aachen, Deutschland

Downloads

Permalink: https://www.hzdr.de/publications/Publ-29649
Publ.-Id: 29649